CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE
Rhea-AI Summary
Core Laboratories (NYSE:CLB) said the Middle East conflict is reducing first quarter 2026 results and issued revised guidance. Revenue is now expected at $119,000,000–$123,000,000, operating income, ex-items at $5,700,000–$7,100,000, and EPS, ex-items at $0.05–$0.07.
The company cited client-driven project delays, travel limits, and supply-chain and maritime logistics constraints, with Reservoir Description most affected and Production Enhancement comparatively less impacted. An earnings webcast is scheduled for April 30, 2026.
Positive
- Revised first-quarter revenue guidance of $119M–$123M
- Operating income, ex-items, guidance provided at $5.7M–$7.1M
- EPS, ex-items, guidance set at $0.05–$0.07
- Production Enhancement business reported as comparatively less affected
Negative
- Revenue and earnings are now expected below prior guidance
- Reservoir Description operations materially disrupted by regional logistics and access issues
- Client-driven project delays, travel constraints, and supply-chain disruptions impacting execution
News Market Reaction – CLB
In the Mar 24 session, CLB declined 6.88%, reflecting a notable negative market reaction. Argus tracked a trough of -3.6% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 04 | Q4 2025 earnings | Positive | -4.2% | Reported Q4 and full-year 2025 growth with improved revenue and earnings. |
| Jan 05 | Earnings call timing | Neutral | +0.2% | Announced Q4 2025 earnings release date and conference call details. |
| Jan 05 | Earnings call timing | Neutral | +0.2% | Reiterated schedule for Q4 2025 earnings release and webcast access. |
| Oct 22 | Q3 2025 earnings | Positive | +28.8% | Delivered Q3 2025 growth, debt reduction, buybacks, and set Q4 guidance. |
| Oct 22 | Q3 2025 earnings | Positive | +28.8% | Highlighted strong Q3 2025 performance and capital allocation actions. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings and related updates have produced varied reactions: one strong rally on Q3 2025 results, a selloff on Q4 2025 results despite growth, and muted moves on scheduling announcements.
Over recent quarters, Core Laboratories reported steady growth, with Q3 2025 revenue of $134.5M and a strong 28.82% price gain after those results. Q4 2025 revenue increased to $138.3M and full-year 2025 revenue reached $526.5M, yet the stock fell 4.23% following that release. Earnings timing announcements on January 5, 2026 had negligible impact. Against this backdrop of generally improving fundamentals but mixed price responses, today’s Middle East–driven guidance cut marks a shift from prior growth-focused updates.
Key Terms
forward-looking statements regulatory
safe harbor provisions regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
FIRST QUARTER 2026 EARNINGS WEBCAST AT 7:30 A.M. CDT / 8:30 A.M. EDT ON APRIL 30, 2026
At this time, due to regional instability, including client-driven project delays, travel constraints, and supply-chain disruptions, the Company expects first quarter 2026 revenue and earnings to be below its previously issued guidance provided on February 4, 2026.
Changes in client activity levels across the
Core's revised guidance for first quarter 2026 revenue ranges from
Core Lab will continue to monitor developments and will provide additional updates as appropriate.
Earnings Call Scheduled
The Company has scheduled a conference call to discuss Core's first quarter 2026 earnings. The call will begin at 7:30 a.m. CDT / 8:30 a.m. EDT on Thursday, April 30, 2026. An earnings press release will be issued after market close on April 29, 2026, and may be accessed through the Company's website at www.corelab.com/investors. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay and transcript will be available on the Company's website shortly after the call.
Core Laboratories Inc. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world. This release, as well as other statements Core Lab makes, includes forward-looking statements regarding the Company's future revenue, profitability, business strategies and developments, demand for the Company's products and services and for products and services of the oil and gas industry generally, made in reliance upon the safe harbor provisions of Federal securities law. The Company's outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business and general economic conditions, including inflationary pressures, the impact of tariffs, trade policies and sanctions, international civil unrest or geopolitical tensions, including the continuing armed conflict between Russia and Ukraine, the escalation of military conflict between
The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.
Visit the Company's website at www.corelab.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/core-lab-announces-impact-of-the-middle-east-conflict-to-first-quarter-2026-guidance-302722501.html
SOURCE Core Laboratories Inc